Article thumbnail

By 

Abstract

Hormone therapy was long consid-ered the best medical therapy for osteoporosis. If it is prescribed for bone health, however, it is no longer the drug of choice in view of its side effect profile. This loss leaves a tremendous thera-peutic gap. Indeed, osteoporosis is a large and growing problem in the United States. Approximately 10 mil-lion American women have osteo-porosis; it has been diagnosed in only 29%, and only 14 % of women with diag-nosed osteoporosis are receiving therapy.1 With life span increasing, a woman today can expect to live to the age of 85 years, living one third of he

Year: 2016
OAI identifier: oai:CiteSeerX.psu:10.1.1.1019.4262
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://jaoa.org/data/Journals/... (external link)
  • http://jaoa.org/data/Journals/... (external link)
  • http://citeseerx.ist.psu.edu/v... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.